GW Pharmaceuticals

Latest stories

6h
Toowoomba Chronicle
How cannabis trial could change Toowoomba familygive access to Epidiolex on a compassionate access scheme which means no placeb
How cannabis trial could change Toowoomba family
Toowoomba Chronicle / Posted 6 hours ago
give access to Epidiolex on a compassionate access scheme which means no placebos will be used in the trials. Developed by GW Pharmaceuticals, Epidiolex is a liquid form of pure cannabidiol and the program will be led by Lady Cilento Children's... Read more
6 related stories
1d
The Daily Mercury
Medical marijuana trial for 30 kids with severe epilepsywould fund a trial into the drug Epidiolex after a Memorandum of Understanding
Medical marijuana trial for 30 kids with severe epilepsy
The Daily Mercury / Posted yesterday
would fund a trial into the drug Epidiolex after a Memorandum of Understanding was signed with the drug's manufacturer GW Pharmaceuticals. "Our project is driven by two things: it is driven by compassion and hope," he said. "The project will... Read more
6 related stories
1d
Toowoomba Chronicle
Medical marijuana trial for 30 kids with severe epilepsywould fund a trial into the drug Epidiolex after a Memorandum of Understanding
Medical marijuana trial for 30 kids with severe epilepsy
Toowoomba Chronicle / Posted yesterday
would fund a trial into the drug Epidiolex after a Memorandum of Understanding was signed with the drug's manufacturer GW Pharmaceuticals. "Our project is driven by two things: it is driven by compassion and hope," he said. "The project will... Read more
6 related stories
1d
Queensland Times
Medical marijuana trial for 30 kids with severe epilepsywould fund a trial into the drug Epidiolex after a Memorandum of Understanding
Medical marijuana trial for 30 kids with severe epilepsy
Queensland Times / Posted yesterday
would fund a trial into the drug Epidiolex after a Memorandum of Understanding was signed with the drug's manufacturer GW Pharmaceuticals. "Our project is driven by two things: it is driven by compassion and hope," he said. "The project will... Read more
6 related stories
1d
The Morning Bulletin
Medical marijuana trial for 30 kids with severe epilepsywould fund a trial into the drug Epidiolex after a Memorandum of Understanding
Medical marijuana trial for 30 kids with severe epilepsy
The Morning Bulletin / Posted yesterday
would fund a trial into the drug Epidiolex after a Memorandum of Understanding was signed with the drug's manufacturer GW Pharmaceuticals. "Our project is driven by two things: it is driven by compassion and hope," he said. "The project will... Read more
6 related stories
1d
News Mail
Medical marijuana trial for 30 kids with severe epilepsywould fund a trial into the drug Epidiolex after a Memorandum of Understanding
Medical marijuana trial for 30 kids with severe epilepsy
News Mail / Posted yesterday
would fund a trial into the drug Epidiolex after a Memorandum of Understanding was signed with the drug's manufacturer GW Pharmaceuticals. "Our project is driven by two things: it is driven by compassion and hope," he said. "The project will... Read more
6 related stories
1d
Australian Broadcasting Corporation
Medicinal cannabis trial available for Queensland children with epilepsythe trial of medical marijuana, but has now signed a memorandum of understandin
Medicinal cannabis trial available for Queensland children with epilepsy
Australian Broadcasting Corporation / Posted yesterday
the trial of medical marijuana, but has now signed a memorandum of understanding with UK-based pharmaceutical company GW Pharmaceuticals to access Epidiolex. Epidiolex is a liquid form of pure cannabidiol. Health Minister Cameron Dick said... Read more
6 related stories
12d
Manning River Times
The illegal life saverchief pharmacist and will also seek to synthesise cannabis compounds in a labor
The illegal life saver
Manning River Times / Posted 12 days ago
chief pharmacist and will also seek to synthesise cannabis compounds in a laboratory,” Professor McGregor said. * In March GW Pharmaceuticals announced the results of a Epidiolex (cannabidiol) study in the treatment of Dravet Syndrome. The... Read more
2 related stories
12d
Manning River Times
The illegal life saverchief pharmacist and will also seek to synthesise cannabis compounds in a labor
The illegal life saver
Manning River Times / Posted 12 days ago
chief pharmacist and will also seek to synthesise cannabis compounds in a laboratory,” Professor McGregor said. * In March GW Pharmaceuticals announced the results of a Epidiolex (cannabidiol) study in the treatment of Dravet Syndrome. The... Read more
2 related stories
12d
Manning River Times
The illegal life saverchief pharmacist and will also seek to synthesise cannabis compounds in a labor
The illegal life saver
Manning River Times / Posted 12 days ago
chief pharmacist and will also seek to synthesise cannabis compounds in a laboratory,” Professor McGregor said. * In March GW Pharmaceuticals announced the results of a Epidiolex (cannabidiol) study in the treatment of Dravet Syndrome. The... Read more
2 related stories
14d
Investors Chronicle
How Aim responded to the Brexit votefallout. Pharmaceutical companies and those which benefit from the strengthenin
How Aim responded to the Brexit vote
Investors Chronicle / Posted 14 days ago
fallout. Pharmaceutical companies and those which benefit from the strengthening price of precious metals, have done well. GW Pharmaceuticals (GWP) and Vernalis(VER) have performed strongly, and pawn broker H&T Group (HAT) has benefited from the... Read more
18d
Op-Ed News
Monsanto, Bayer, and the Push for Corporate CannabisHortapharm has since 1990 created the world's largest collection of Cannabis se
Monsanto, Bayer, and the Push for Corporate Cannabis
Op-Ed News / Posted 18 days ago
Hortapharm has since 1990 created the world's largest collection of Cannabis seed varieties. In 1998, the British firm GW Pharmaceuticals signed an agreement with Hortapharm that gives GW Pharma the rights to use the Hortapharm cannabis for... Read more
20d
Investors Chronicle
Breakthrough biotechmany of those aren’t even undergoing expensive clinical trials yet. Two of the
Breakthrough biotech
Investors Chronicle / Posted 20 days ago
many of those aren’t even undergoing expensive clinical trials yet. Two of the UK’s biggest biotech hopefuls, Circassia and GW Pharmaceuticals (GWP), spent £47m and £75m respectively on R&D last year. Therefore the ability to raise extra funds is... Read more
21d
FOX Business
Here's Why This Marijuana Stock Marched 10.6% Higher in JuneImage source: GW Pharmaceuticals. What: After reporting that its marijuana-der
Here's Why This Marijuana Stock Marched 10.6% Higher in June
FOX Business / Posted 21 days ago
Image source: GW Pharmaceuticals. What: After reporting that its marijuana-derived drug Epidiolex reduced the number of monthly seizures in patients with Lennox-Gastaut syndrome (LGS), GW Pharmaceuticals Plc shares jumped 10.6% last month,according... Read more
21d
FOX Business
Here's Why This Marijuana Stock Marched 10.6% Higher in JuneImage source: GW Pharmaceuticals. Continue Reading Below What: After reportin
Here's Why This Marijuana Stock Marched 10.6% Higher in June
FOX Business / Posted 21 days ago
Image source: GW Pharmaceuticals. Continue Reading Below What: After reporting that its marijuana-derived drug Epidiolex reduced the number of monthly seizures in patients with Lennox-Gastaut syndrome (LGS), GW Pharmaceuticals Plc shares jumped... Read more
21d
Reading Evening Post
Thousands of University of Reading students celebrate graduationof science. With more than 30 years of experience in medical research and globa
Thousands of University of Reading students celebrate graduation
Reading Evening Post / Posted 21 days ago
of science. With more than 30 years of experience in medical research and global drug development, Dr Guy is the founder of GW Pharmaceuticals and has served as its chairman since 1998. Investing in education : Mary Riall will be presented an... Read more
22d
The Advocate
Louisiana Sheriffs' Association leaders: Balance needed on medical marijuanaof cannabidiol) revealed positive outcomes for children suffering from two epil
Louisiana Sheriffs' Association leaders: Balance needed on medical marijuana
The Advocate / Posted 22 days ago
of cannabidiol) revealed positive outcomes for children suffering from two epileptic seizure disorders. The manufacturer, GW Pharmaceuticals, is expected to file for a new drug application this year with the FDA. One of the major hurdles patients... Read more
26d
Market Watch
How the DEA could introduce big pharma to marijuanaA treatment for weight loss and nausea in AIDS and chemotherapy patients, it co
How the DEA could introduce big pharma to marijuana
Market Watch / Posted 26 days ago
A treatment for weight loss and nausea in AIDS and chemotherapy patients, it contains synthetic THC. And London-based GW Pharmaceuticals GWPH, +2.38% has come close to completing the FDA approval process for a CBD-derived drug after reporting... Read more
28d
KETV 7 Omaha
UNMC launches study of medical cannabisspring of 2015 to get Epidiolex, a plant-based pharmaceutical formulation of pu
UNMC launches study of medical cannabis
KETV 7 Omaha / Posted 28 days ago
spring of 2015 to get Epidiolex, a plant-based pharmaceutical formulation of pure cannabidiol, from United Kingdom-based GW Pharmaceuticals. Lining up the legal supply led to support from Gov. Pete Ricketts, who then signed the bill authorizing... Read more
30d
ABC Action News Tampa Bay
Clinical Trial Offers New Hope For Marijuana-Based Prescription Drugsand 55 years old and took Epidiolex in addition to their other anti-epileptic m
Clinical Trial Offers New Hope For Marijuana-Based Prescription Drugs
ABC Action News Tampa Bay / Posted 30 days ago
and 55 years old and took Epidiolex in addition to their other anti-epileptic medication. The company that makes the drug, GW Pharmaceuticals, told outlets it will likely apply for U.S. market approval by 2017. This video includes images from GW... Read more
3 related stories
30d
KIVI Boise
Clinical Trial Offers New Hope For Marijuana-Based Prescription Drugsand 55 years old and took Epidiolex in addition to their other anti-epileptic m
Clinical Trial Offers New Hope For Marijuana-Based Prescription Drugs
KIVI Boise / Posted 30 days ago
and 55 years old and took Epidiolex in addition to their other anti-epileptic medication. The company that makes the drug, GW Pharmaceuticals, told outlets it will likely apply for U.S. market approval by 2017. This video includes images from GW... Read more
3 related stories
30d
FOX Business
Marijuana Delivers Another Big Win in EpilepsyImage source: GW Pharmaceuticals. Building on its success in treating a rare f
Marijuana Delivers Another Big Win in Epilepsy
FOX Business / Posted 30 days ago
Image source: GW Pharmaceuticals. Building on its success in treating a rare form of epilepsy known as Dravet syndrome earlier this year, marijuana has now shown that it can be used to reduce seizures in patients suffering from Lennox-Gastaut... Read more
3 related stories
30d
FOX Business
Marijuana Delivers Another Big Win in EpilepsyImage source: GW Pharmaceuticals. Continue Reading Below Building on its succ
Marijuana Delivers Another Big Win in Epilepsy
FOX Business / Posted 30 days ago
Image source: GW Pharmaceuticals. Continue Reading Below Building on its success in treating a rare form of epilepsy known as Dravet syndrome earlier this year, marijuana has now shown that it can be used to reduce seizures in patients suffering... Read more
3 related stories
30d
FOX Business
Why Heartware International, GW Pharmaceuticals, and Randgold Resources Jumped Todaystocks managed to avoid the downdraft and post substantial gains. Among the bes
Why Heartware International, GW Pharmaceuticals, and Randgold Resources Jumped Today
FOX Business / Posted 30 days ago
stocks managed to avoid the downdraft and post substantial gains. Among the best performers were Heartware International , GW Pharmaceuticals , and Randgold Resources . A big buyout lifts Heartware Heartware soared 93% after getting a buyout bid... Read more
30d
FOX Business
Why Heartware International, GW Pharmaceuticals, and Randgold Resources Jumped Todaystocks managed to avoid the downdraft and post substantial gains. Among the bes
Why Heartware International, GW Pharmaceuticals, and Randgold Resources Jumped Today
FOX Business / Posted 30 days ago
stocks managed to avoid the downdraft and post substantial gains. Among the best performers were Heartware International , GW Pharmaceuticals , and Randgold Resources . A big buyout lifts Heartware Heartware soared 93% after getting a buyout bid... Read more
30d
Fortune
Here's Why This Marijuana Drug Company's Stock Is Soaring TodayGW Pharmaceuticals gwph could be on its way to eventually winning the first U.S
Here's Why This Marijuana Drug Company's Stock Is Soaring Today
Fortune / Posted 30 days ago
GW Pharmaceuticals gwph could be on its way to eventually winning the first U.S. approval for a marijuana-based prescription drug. The U.K.-based biopharma on Monday unveiled more data finding that its investigational therapy Epidiolex, which is... Read more
30d
FOX Business
Why GW Pharmaceuticals Stock Is Shrugging Off the Brexit SellImage source: Getty Images. What: While the broader markets are heading south
Why GW Pharmaceuticals Stock Is Shrugging Off the Brexit Sell
FOX Business / Posted 30 days ago
Image source: Getty Images. What: While the broader markets are heading south today on the Brexit vote, shares of GW Pharmaceuticals gained as much as 12.4% on a positive clinical update for its marijuana-derived epilepsy medicine Epidiolex.... Read more
3 related stories
30d
FOX Business
Why GW Pharmaceuticals Stock Is Shrugging Off the Brexit SellImages. Continue Reading Below What: While the broader markets are heading so
Why GW Pharmaceuticals Stock Is Shrugging Off the Brexit Sell
FOX Business / Posted 30 days ago
Images. Continue Reading Below What: While the broader markets are heading south today on the Brexit vote, shares of GW Pharmaceuticals gained as much as 12.4% on a positive clinical update for its marijuana-derived epilepsy medicine... Read more
3 related stories
30d
WTAE-TV Pittsburgh
(REPLAY) Chronicle: Compassion and CannabisSYDNEY HAS HER BROTHER, WHO HAS HAD A COUPLE OF SEIZURES, BUT IS DOING FINE. PA
(REPLAY) Chronicle: Compassion and Cannabis
WTAE-TV Pittsburgh / Posted 30 days ago
SYDNEY HAS HER BROTHER, WHO HAS HAD A COUPLE OF SEIZURES, BUT IS DOING FINE. PAUL REVEALS THAT HE AND HIS LIFE. CB OIL FROM GW PHARMACEUTICALS, A BRITISH COMPANY. OIL. RESPONSIBLE FOR MOST OF THE MARIJUANA HIGH. >> WE HAVE BEEN HOLD THAT THE TO 1... Read more
1m
Business Insider
A drug derived from marijuana is working for people with a rare form of epilepsy — and the company’s stock is taking off22%. Lennox-Gastaut Syndrome is a rare form of childhood-onset epilepsy that's
A drug derived from marijuana is working for people with a rare form of epilepsy — and the company’s stock is taking off
Business Insider / Posted a month ago
22%. Lennox-Gastaut Syndrome is a rare form of childhood-onset epilepsy that's associated with multiple types of seizures. GW Pharmaceuticals, the company developing Epidiolex, was up more than 10% on Monday. If approved, it would be the first of... Read more
3 related stories
m
FOX Business
Arguably the Most Important Marijuana Decision Ever Is Just Weeks Awaythat marijuana could indeed have benefits. A liquid cannabidiol-based formulati
Arguably the Most Important Marijuana Decision Ever Is Just Weeks Away
FOX Business / Posted 1 months ago
that marijuana could indeed have benefits. A liquid cannabidiol-based formulation currently in late-stage studies by GW Pharmaceuticals , known as Epidiolex, has helped to reduce seizure frequency in patients with Dravet syndrome, a type of... Read more
m
FOX Business
Arguably the Most Important Marijuana Decision Ever Is Just Weeks Awaythat marijuana could indeed have benefits. A liquid cannabidiol-based formulati
Arguably the Most Important Marijuana Decision Ever Is Just Weeks Away
FOX Business / Posted 1 months ago
that marijuana could indeed have benefits. A liquid cannabidiol-based formulation currently in late-stage studies by GW Pharmaceuticals , known as Epidiolex, has helped to reduce seizure frequency in patients with Dravet syndrome, a type of... Read more

People in this news